<?xml version="1.0" encoding="UTF-8"?>
<p>Whether the prevalence of COVID-19 in patients with cancer, including CLL, is higher than in sex- and age-matched normal population is uncertain.
 <sup>
  <xref rid="R3" ref-type="bibr">3</xref>–
  <xref rid="R5" ref-type="bibr">5</xref>
 </sup> However, there is evidence that cancer conveys a poorer outcome in patients with COVID-19 infection.
 <sup>
  <xref rid="R3" ref-type="bibr">3</xref>–
  <xref rid="R10" ref-type="bibr">10</xref>
 </sup> In addition, the risk of COVID-19 morbidity and mortality is thought to be higher in CLL due to the detrimental effect of comorbidities frequently occurring in patients with this leukemia, though this aspect has not been specifically addressed.
</p>
